Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin
Junior, Wellington Fernandes da Silva, Marquez, Gabriel Lacerda, Salim, Rafael Calil, Rocha, VandersonJournal:
Hematology, Transfusion and Cell Therapy
DOI:
10.1016/j.htct.2018.11.004
Date:
March, 2019
File:
PDF, 709 KB
2019